Benutzer: Gast  Login
Titel:

Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics

Dokumenttyp:
Zeitschriftenaufsatz
Autor(en):
Chang, Yun-Chien; Gnann, Christian; Steimbach, Raphael R.; Bayer, Florian P.; Lechner, Severin; Sakhteman, Amirhossein; Abele, Miriam; Zecha, Jana; Trendel, Jakob; The, Matthew; Lundberg, Emma; Miller, Aubry K.; Kuster, Bernhard
Abstract:
Lysine deacetylase inhibitors (KDACis) are approved drugs for cutaneous T cell lymphoma (CTCL), peripheral T cell lymphoma (PTCL), and multiple myeloma, but many aspects of their cellular mechanism of action (MoA) and substantial toxicity are not well understood. To shed more light on how KDACis elicit cellular responses, we systematically measured dose-dependent changes in acetylation, phosphorylation, and protein expression in response to 21 clinical and pre-clinical KDACis. The resulting 862,...     »
Stichworte:
BayBioMS; CP: Molecular biology; HDACs; acetylation; chemical proteomics; lysine deacetylase inhibitors; mass spectrometry; phosphorylation; proteomic pharmacology
Zeitschriftentitel:
Cell Reports
Jahr:
2024
Band / Volume:
43
Heft / Issue:
6
Seitenangaben Beitrag:
114272
Volltext / DOI:
doi:10.1016/j.celrep.2024.114272
Verlag / Institution:
Elsevier BV
E-ISSN:
2211-1247
Publikationsdatum:
01.06.2024
 BibTeX